Sanofi-China (01672.HK): The combination of ASC47 with semaglutide in obese subjects resulted in a relative increase in weight loss efficacy of up to 56.2% compared to semaglutide monotherapy.

Zh tng cijng APP xn, g l zh yo -B (01672.HK) fb gnggo, zi d 29 tin sh, jin zhng b jin j huxun yow ASC47 y s mi g l pi linyng zi fipng shu sh zh (tzhng zhsh 30kg/m) zhng ji nwi j s mi g l pi linyng (s mi g l pi dnyo) jin zhng xiogu xingdu tgo god 56.2%.